However, from there on, the research field of the TME moved forward, expanding and enlarging its scope to new frontiers. Among the topics that were explored in the early eighties were interactions between the extracellular matrix (ECM) and tumor cells [60–64] and between fibroblasts and tumor cells [65–67]. These and other studies published at that time indicated that tumor-ECM or tumor-fibroblast interactions may exert either anti tumor effects or the opposite, namely pro malignancy

effects. Rudolph Virchow’s paradigm that inflammation contributes to carcinogenesis and tumor progression [68] has developed Selleck SBI-0206965 into one of the major and most important aspects of the TME area. It was demonstrated that inflammatory cells (mainly macrophages) as well as proinflammatory molecules such as cytokines and chemokines whose physiologic function is to constitute a firewall against infectious agents, are causally involved in the initiation of certain types of cancer (inflammation-linked cancers) or in tumor progression of essentially all types of cancer [69, 70]. As mentioned above, several studies from

the seventies of last century reported that BTSA1 solubility dmso mononuclear cells infiltrate solid tumors [19, 20, 26, 27, 29, 33, 35, 36]. It took several years to establish that such cells are heavily involved in the pro malignancy functions of cancer-linked inflammation [69–72]. However, many, if not most components of the TME may, under certain circumstances, exert anti malignancy activities whereas under different circumstances, they Rapamycin exert pro malignancy effects [73]. Tumor infiltrating macrophages are no exception [74–78]. The contemporary studies on tumor infiltrating macrophages tend, however, to stress their pro malignancy effects rather than the anti malignancy functions of these

cells [71, 79–86]. Angiogenesis, the immune context of tumors, the interrelationships of tumor cells with fibroblasts, components of the ECM and pro-inflammatory mediators are among the cutting edge topics of contemporary TME research. It is important to realize that the pioneering studies in these areas were undertaken at a time in which cancer genetics dominated the scene. The discoveries made in cancer genetics in the three decade period from the early seventies until the end the nineties are undoubtedly the golden era of this research 3-mercaptopyruvate sulfurtransferase domain. The prevailing and dominating concept at that time was that genetic alterations in oncogenes and tumor suppressor genes are both necessary and sufficient to initiate tumorigenesis and drive tumor progression. What, if any was the relationship between cancer geneticists and the “individuals who study the properties of the host environment” (to use Auerbach’s words)? Obviously both groups focused on different aspects of malignancy, holding, most probably opposing views as to the relative importance of cancer genes or of the TME to the pathophysiology of cancer.